The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States

Avirup Guha; Grant McKinley; Amit K. Dey; Rebecca Carter; P. Elliott Miller; Abhishek J. Deshmukh; Raja Zaghlol; Ana Barac; Nihar R. Desai; Daniel Addison

doi:10.1111/jocs.14444

The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States

Avirup Guha, Grant McKinley, Amit K. Dey, Rebecca Carter, P. Elliott Miller, Abhishek J. Deshmukh, Raja Zaghlol, Ana Barac, Nihar R. Desai, Daniel Addison

Cardiology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Background: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure. Methods: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states). Results: In those presenting with VTE during index-admission (619 241), 2.4% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3% in those with cancer compared to 8.8% in those with no cancer history (P

Original language	English (US)
Pages (from-to)	609-611
Number of pages	3
Journal	Journal of Cardiac Surgery
Volume	35
Issue number	3
DOIs	https://doi.org/10.1111/jocs.14444
State	Published - Mar 1 2020

Keywords

cancer
catheter directed thrombolytic
cost of care
readmission
venous thromboembolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jocs.14444

Cite this

Guha, A., McKinley, G., Dey, A. K., Carter, R., Miller, P. E., Deshmukh, A. J., Zaghlol, R., Barac, A., Desai, N. R., & Addison, D. (2020). The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States. Journal of Cardiac Surgery, 35(3), 609-611. https://doi.org/10.1111/jocs.14444

Guha, A, McKinley, G, Dey, AK, Carter, R, Miller, PE, Deshmukh, AJ, Zaghlol, R, Barac, A, Desai, NR & Addison, D 2020, 'The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States', Journal of Cardiac Surgery, vol. 35, no. 3, pp. 609-611. https://doi.org/10.1111/jocs.14444

@article{0a6b72f5d8ab49d8800db86b5b568796,

title = "The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States",

abstract = "Background: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure. Methods: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states). Results: In those presenting with VTE during index-admission (619 241), 2.4% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3% in those with cancer compared to 8.8% in those with no cancer history (P ",

keywords = "cancer, catheter directed thrombolytic, cost of care, readmission, venous thromboembolism",

author = "Avirup Guha and Grant McKinley and Dey, {Amit K.} and Rebecca Carter and Miller, {P. Elliott} and Deshmukh, {Abhishek J.} and Raja Zaghlol and Ana Barac and Desai, {Nihar R.} and Daniel Addison",

year = "2020",

month = mar,

day = "1",

doi = "10.1111/jocs.14444",

language = "English (US)",

volume = "35",

pages = "609--611",

journal = "Journal of Cardiac Surgery",

issn = "0886-0440",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States

AU - Guha, Avirup

AU - McKinley, Grant

AU - Dey, Amit K.

AU - Carter, Rebecca

AU - Miller, P. Elliott

AU - Deshmukh, Abhishek J.

AU - Zaghlol, Raja

AU - Barac, Ana

AU - Desai, Nihar R.

AU - Addison, Daniel

PY - 2020/3/1

Y1 - 2020/3/1

N2 - Background: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure. Methods: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states). Results: In those presenting with VTE during index-admission (619 241), 2.4% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3% in those with cancer compared to 8.8% in those with no cancer history (P

AB - Background: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure. Methods: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states). Results: In those presenting with VTE during index-admission (619 241), 2.4% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3% in those with cancer compared to 8.8% in those with no cancer history (P

KW - cancer

KW - catheter directed thrombolytic

KW - cost of care

KW - readmission

KW - venous thromboembolism

UR - https://www.mendeley.com/catalogue/a587a742-9d11-3ad7-8092-e71c6af7bdf7/

U2 - 10.1111/jocs.14444

DO - 10.1111/jocs.14444

M3 - Article

C2 - 32017181

SN - 0886-0440

VL - 35

SP - 609

EP - 611

JO - Journal of Cardiac Surgery

JF - Journal of Cardiac Surgery

IS - 3

ER -

The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this